We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$407M
Cap. Flow
+$540M
Cap. Flow %
22.68%
Top 10 Hldgs %
32.09%
Holding
169
New
35
Increased
72
Reduced
38
Closed
24

Top Sells

Rank Stock Value
1
COUR icon
Coursera
COUR
+$25.2M
2
APP icon
Applovin
APP
+$22.4M
3
CTSH icon
Cognizant
CTSH
+$20.7M
4
CPAY icon
Corpay
CPAY
+$19.5M
5
AKAM icon
Akamai
AKAM
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Communication Services 13.73%
3 Healthcare 12.21%
4 Consumer Discretionary 11.73%
5 Energy 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUN icon
76
Cedar Fair
FUN
$1.62B
$7.78M 0.33%
210,285
-7,266
-3% -$283K
HRT
77
DELISTED
HireRight Holdings Corporation
HRT
$7.74M 0.33%
813,461
-2,749
-0.3% -$28.4K
NGD
78
DELISTED
New Gold Inc
NGD
$7.69M 0.32%
8,446,768
+2,488,498
+42% +$2.65M
LUV icon
79
Southwest Airlines
LUV
$22B
$7.52M 0.32%
277,747
-9,510
-3% -$310K
GDRX icon
80
GoodRx Holdings
GDRX
$1.25B
$7.35M 0.31%
+1,306,196
New +$8.71M
MATV icon
81
Mativ Holdings
MATV
$706M
$7.31M 0.31%
512,672
+262,128
+105% +$4.19M
GEN icon
82
Gen Digital
GEN
$17.5B
$7.06M 0.3%
399,065
+158,185
+66% +$3.09M
DMC
83
Del Monte Corp
DMC
$1.43B
$6.9M 0.29%
+266,908
New +$6.98M
ALE
84
DELISTED
Allete
ALE
$6.39M 0.27%
+120,987
New +$6.81M
UFI icon
85
UNIFI
UFI
$129M
$6.3M 0.26%
887,161
-1,801
-0.2% -$13.4K
VMEO
86
DELISTED
Vimeo
VMEO
$6.18M 0.26%
1,745,568
+46,588
+3% +$185K
SSL icon
87
Sasol
SSL
$7.38B
$5.95M 0.25%
435,135
+162,712
+60% +$2.13M
EQX icon
88
Equinox Gold
EQX
$13.5B
$5.77M 0.24%
1,363,964
+429,172
+46% +$2.07M
NTGR icon
89
NETGEAR
NTGR
$619M
$5.76M 0.24%
457,377
+295,839
+183% +$3.92M
TNDM icon
90
Tandem Diabetes Care
TNDM
$1.59B
$5.66M 0.24%
272,444
+190,273
+232% +$5.23M
CPA icon
91
Copa Holdings
CPA
$5.58B
$5.46M 0.23%
61,308
-45,293
-42% -$4.7M
WRK
92
DELISTED
WestRock Company
WRK
$5.38M 0.23%
150,223
-5,151
-3% -$169K
MG icon
93
Mistras Group
MG
$502M
$5.25M 0.22%
963,777
-81,520
-8% -$512K
ENPH icon
94
Enphase Energy
ENPH
$5.41B
$4.93M 0.21%
+41,023
New +$5.84M
PRAA icon
95
PRA Group
PRAA
$723M
$4.91M 0.21%
255,396
+204,716
+404% +$4.31M
CSTL icon
96
Castle Biosciences
CSTL
$988M
$4.83M 0.2%
285,957
+7,139
+3% +$125K
SNAP icon
97
Snap
SNAP
$9.05B
$4.82M 0.2%
540,539
-526,095
-49% -$5.5M
SD icon
98
SandRidge Energy
SD
$531M
$4.78M 0.2%
304,963
+7,230
+2% +$116K
WWW icon
99
Wolverine World Wide
WWW
$1.55B
$4.6M 0.19%
+570,630
New +$5.87M
EXFY icon
100
Expensify
EXFY
$225M
$4.46M 0.19%
1,373,584
+9,620
+0.7% +$52K

Similar funds

Invenomic Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.

  • Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
  • Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
  • Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
  • Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
  • Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
  • Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.